Difficulty: Medium
Average Score: 81%
Practice
A 69-year-old female patient has been diagnosed with malignant melanoma. The care team has collaborated with the patient and her family and agreed on a plan of care that includes administration of interferon alfa-2b. After administering interferon alfa-2b, the oncology nurse should anticipate that the patient may develop which of the following adverse effects?
Correct answer
C
Rationale
Interferon alfa-2b, used in melanoma to boost immunity, commonly triggers flu-like symptoms fever, chills, fatigue, aches within hours, lasting up to a day, due to cytokine-induced systemic inflammation. Diaphoresis, consciousness drops, or cyanosis aren't typical; these suggest other issues. The nurse anticipates this reaction, reflecting interferon's immunostimulatory effects, preparing the patient for manageable, transient discomfort, consistent with its well-documented side effect profile in cancer therapy.